Insider · CIK 0001538897

Alles Mark J

Reports to the SEC for 4 companies · SUMMIT, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001538897

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-16	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,666 sh	—	—	3,666
2023-09-16	Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,666 sh	—	—	5,334
2023-06-01	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000
2023-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-05-23	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,190 sh	—	—	15,095
2022-10-31	BMRNBIOMARIN PHARMACEUTICAL INCP Purchase	Director	PPurchase	+3,625 sh	$86.75	+$314K	10,905
2022-09-16	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-08-17	Turning Point Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	$76.00	−$152K	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−209 sh	—	—	0
2022-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-05-24	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,980 sh	—	—	7,280
2022-01-03	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,300 sh	—	—	2,300
2021-06-21	Turning Point Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	$81.34	+$163K	2,000
2021-06-08	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-06-02	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+209 sh	—	—	209
2021-05-24	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2020-06-11	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-05-13	Syros Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+10K sh	$8.86	+$88.6K	10,000
2019-12-19	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−8,625 sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−33.9K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−8,625 sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−33.9K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−33.9K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−15.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−59.2K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−59.2K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−59.2K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−20.4K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−33.9K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−29.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−8,625 sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−29.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−17.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−366K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−12.5K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−17.5K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−8,326 sh	—	—	0
2019-11-20	CELGENE CORP /DE/A Award	Director, CEO, CHAIRMAN OF BOARD	AAward	+74.4K sh	—	—	366,495
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−17.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/A Award	Director, CEO, CHAIRMAN OF BOARD	AAward	+45.1K sh	—	—	292,081
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−17.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−19.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−17.7K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−8,326 sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−10.2K sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−8,326 sh	—	—	0
2019-11-20	CELGENE CORP /DE/Stock Option (right to buy)D Disposition to Issuer	Director, CEO, CHAIRMAN OF BOARD	DDisposition to Issuer	−11K sh	—	—	0

Recent filings

Accepted (ET)
Sep 194
Alles Mark J0001209191-23-049977
SEC(opens sec.gov)
Jun 24
Alles Mark J0001209191-23-033715
SEC(opens sec.gov)
May 244
Alles Mark J0001209191-23-031964
SEC(opens sec.gov)
Nov 24
Alles Mark J0001567619-22-019081
SEC(opens sec.gov)
Sep 194
Alles Mark J0001209191-22-050549
SEC(opens sec.gov)
Aug 174
Alles Mark J0001209191-22-046273
SEC(opens sec.gov)
Jun 24
Alles Mark J0001209191-22-033704
SEC(opens sec.gov)
May 264
Alles Mark J0001567619-22-011784
SEC(opens sec.gov)
Jan 54
Alles Mark J0001567619-22-000661
SEC(opens sec.gov)
Jun 214
Alles Mark J0001209191-21-042325
SEC(opens sec.gov)
Jun 104
Alles Mark J0001209191-21-039572
SEC(opens sec.gov)
Jun 44
Alles Mark J0001209191-21-038329
SEC(opens sec.gov)
May 264
Alles Mark J0001209191-21-035956
SEC(opens sec.gov)
Jun 114
Alles Mark J0001209191-20-035965
SEC(opens sec.gov)
May 134
Alles Mark J0001209191-20-028871
SEC(opens sec.gov)

Companies

Address

C/O CELGENE CORPORATION 86 MORRIS AVENUE

SUMMIT, NJ, 07901